Truace
Subscribe

Can a new AI tool predict whether you will survive cancer from a selfie?

US-based researchers have built an AI tool that can predict cancer patients’ survival chances by using a single photograph of their face. While it’s not ready for widespread use, it could help doctors recommend the right treatments for their patients More often than not, selfies are considered an act of vanity. But what if a selfie could be much more? What if a single photo of your face could estimate one’s biological age and a cancer patient’s survival chances? That’s what researchers at Mass Ge

By the Truvace desk1 min read1 sourceJournalismTRV-2026-2143· cite & verify
Can a new AI tool predict whether you will survive cancer from a selfie?

In brief

Researchers in the United States have developed an artificial intelligence system that analyses a single photograph of a person's face. The tool is meant to estimate biological age and, for cancer patients, their likelihood of survival.

The idea matters because a simple image could offer clinicians an additional input when choosing treatments. The supplied text, however, is cut off early, and it states the tool is not ready for widespread use, so its accuracy and real-world performance remain unestablished here.

Main points

  1. The tool uses one photograph of a patient's face as its input.
  2. It aims to predict survival chances for people with cancer.
  3. The article also says a face photo could estimate a person's biological age.
  4. The researchers are described as US-based, with Mass Ge cut off in the text.
  5. The tool is described as not ready for widespread use.

The gain

An AI tool built by US researchers uses a single facial photograph to predict cancer patients' survival chances, which could help doctors recommend suitable treatments.

The rundown

The article opens by contrasting the usual view of selfies as vanity with the possibility that a face photo could carry medical information. It frames the work as an explainer on whether an image can reveal how long a cancer patient may survive.

According to the standfirst, the intended benefit is clinical: better-informed treatment recommendations from doctors. The supplied excerpt gives no study design, sample size, accuracy figures, or validation details, so none can be assessed from this text.

Sources

  1. JournalismFirstpost2026-10-21

The debate